Skip to main content

Akumin Stock Forecast, Price & News

-0.08 (-2.60 %)
(As of 05/12/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume32,651 shs
Average Volume131,996 shs
Market Capitalization$213.46 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive AKU News and Ratings via Email

Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter.

Akumin logo

About Akumin

Akumin Inc. provides outpatient diagnostic imaging services in the United States. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The company provides various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures; and online medical bill payment services. As of December 31, 2020, the company operated 127 outpatient diagnostic imaging centers located in Florida, Texas, Pennsylvania, Delaware, Georgia, Illinois, and Kansas. Akumin Inc. is headquartered in Plantation, Florida.


See More Headlines

Industry, Sector and Symbol

Industry Diagnostics & Research
Current SymbolNASDAQ:AKU
Phone416 613 1391
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Market Cap$213.46 million
Next Earnings Date6/30/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

0.58 out of 5 stars

Medical Sector

1439th out of 2,045 stocks

Diagnostics & Research Industry

8th out of 15 stocks

Analyst Opinion: 0.0Community Rank: 1.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Akumin (NASDAQ:AKU) Frequently Asked Questions

Is Akumin a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akumin in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Akumin stock.
View analyst ratings for Akumin
or view top-rated stocks.

What stocks does MarketBeat like better than Akumin?

Wall Street analysts have given Akumin a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Akumin wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Akumin?

Akumin saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 11,500 shares, an increase of 150.0% from the March 31st total of 4,600 shares. Based on an average daily volume of 169,000 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the shares of the stock are short sold.
View Akumin's Short Interest

When is Akumin's next earnings date?

Akumin is scheduled to release its next quarterly earnings announcement on Wednesday, June 30th 2021.
View our earnings forecast for Akumin

How were Akumin's earnings last quarter?

Akumin Inc. (NASDAQ:AKU) released its quarterly earnings data on Wednesday, March, 31st. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.13. The company had revenue of $58.20 million for the quarter.
View Akumin's earnings history

What guidance has Akumin issued on next quarter's earnings?

Akumin issued an update on its FY 2021 earnings guidance on Tuesday, April, 27th. The company provided earnings per share guidance of - for the period. The company issued revenue guidance of $270 million-$279 million, compared to the consensus revenue estimate of $305.84 million.

Who are Akumin's key executives?

Akumin's management team includes the following people:
  • Mr. Riadh Zine-El-Abidine, Pres, CEO & Director (Age 49, Pay $1.26M)
  • Mr. Mohammad Saleem, CFO & Corp. Sec.
  • Mr. Rohit Navani, Exec. VP & COO
  • Mr. Matthew Cameron, Sr. VP & Gen. Counsel
  • Mr. Christopher Fitzgerald, Chief Revenue Officer
  • Darren Speed, Chief Compliance Officer
  • Karen Moore, VP of HR
  • Ms. Laura Kassa, Sr. VP
  • Adam Fabian, Corp. Controller
  • Mr. Kevin G. Johnson, CEO & Pres of Advanced Diagnostic Group, LLC

Who are some of Akumin's key competitors?

What is Akumin's stock symbol?

Akumin trades on the NASDAQ under the ticker symbol "AKU."

Who are Akumin's major shareholders?

Akumin's stock is owned by many different institutional and retail investors. Top institutional shareholders include Montrusco Bolton Investments Inc. (3.18%), CIBC World Markets Inc. (0.61%), King Luther Capital Management Corp (0.34%) and Geode Capital Management LLC (0.03%).

Which major investors are buying Akumin stock?

AKU stock was bought by a variety of institutional investors in the last quarter, including Montrusco Bolton Investments Inc., King Luther Capital Management Corp, Geode Capital Management LLC, and CIBC World Markets Inc..

How do I buy shares of Akumin?

Shares of AKU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Akumin's stock price today?

One share of AKU stock can currently be purchased for approximately $3.00.

How much money does Akumin make?

Akumin has a market capitalization of $213.46 million.

How many employees does Akumin have?

Akumin employs 1,737 workers across the globe.

What is Akumin's official website?

The official website for Akumin is

How can I contact Akumin?

The company can be reached via phone at 416 613 1391.

This page was last updated on 5/13/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.